| # | Drug | Count |
|---|---|---|
| 0 | PALBOCICLIB | 10 |
| 1 | LETROZOLE | 8 |
| 2 | LETROZOLE TABLETS | 7 |
| 3 | CISPLATIN | 6 |
| 4 | ENOXAPARIN SODIUM | 5 |
| 5 | EVEROLIMUS | 5 |
| 6 | INSULIN GLARGINE | 5 |
| 7 | CAPECITABINE | 4 |
| 8 | CARBOPLATIN | 3 |
| 9 | FULVESTRANT | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SODIUM IODIDE I 123 | 1 | 0.0011 |
| 1 | SODIUM IODIDE I 131 | 1 | 0.0010 |
| 2 | PAMIDRONATE DISODIUM | 3 | 0.0009 |
| 3 | ESTRADIOL/NORETHINDRONE ACETATE | 1 | 0.0005 |
| 4 | NICARDIPINE HYDROCHLORIDE | 1 | 0.0004 |
| 5 | CEFIXIME | 1 | 0.0003 |
| 6 | AMIVANTAMAB-VMJW | 1 | 0.0003 |
| 7 | QUININE | 2 | 0.0002 |
| 8 | NICARDIPINE | 1 | 0.0002 |
| 9 | EPIRUBICIN HYDROCHLORIDE | 1 | 0.0002 |
| # | Drug class | Count |
|---|---|---|
| 0 | Kinase Inhibitor [EPC] | 19 |
| 1 | Aromatase Inhibitor [EPC] | 10 |
| 2 | Platinum-based Drug [EPC] | 9 |
| 3 | Corticosteroid [EPC] | 7 |
| 4 | Insulin Analog [EPC] | 6 |
| 5 | Benzodiazepine [EPC] | 5 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 5 |
| 7 | mTOR Inhibitor Immunosuppressant [EPC] | 5 |
| 8 | Alkylating Drug [EPC] | 3 |
| 9 | Estrogen Receptor Antagonist [EPC] | 3 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 1 | Programmed Death Ligand-1 Blocker [EPC] | 2 | 0.0001 |
| 2 | Aromatase Inhibitor [EPC] | 10 | 0.0001 |
| 3 | Estrogen Receptor Antagonist [EPC] | 3 | 0.0001 |
| 4 | Stimulant Laxative [EPC] | 1 | 0.0001 |
| 5 | Provitamin D2 Compound [EPC] | 2 | 0.0001 |
| 6 | Anticholinergic [EPC] | 1 | 0.0001 |
| 7 | HER2/neu Receptor Antagonist [EPC] | 3 | 0.0000 |
| 8 | Gonadotropin Releasing Hormone Receptor Antagonist [EPC] | 1 | 0.0000 |
| 9 | Kinase Inhibitor [EPC] | 19 | 0.0000 |